TGFβ-mediated downregulation of thrombopoietin is associated with platelet decline in asymptomatic SIV infection

Kelly A.Metcalf Pate, Claire E. Lyons, Jamie L. Dorsey, Suzanne E. Queen, Robert J. Adams, Craig N. Morrell, Joseph L. Mankowski

Research output: Contribution to journalArticle

Abstract

Background: Thrombocytopenia is a known consequence of HIV infection, and decreased production of platelets has been previously implicated in the pathogenesis of platelet decline during asymptomatic infection. Thrombopoietin (THPO) drives platelet production by stimulating the maturation of bone marrow megakaryocytes and can be transcriptionally downregulated by cytokines that are increased during infection such as transforming growth factor b (TGFβ) and platelet factor 4 (pf4). Design: To determine whether transcriptional downregulation of THPO contributed to decreased platelet production during asymptomatic infection in the simian immunodeficiency virus (SIV)/ macaque model of HIV, we compared hepatic THPO mRNA levels to platelet number and megakaryocyte density. To identify potential inhibitory factors that decrease THPO transcription during asymptomatic infection, we measured TGFβ and pf4 plasma levels. To determine whether combined antiretroviral therapy (cART) could correct platelet decline by altering cytokine levels, we measured TGFβ and pf4 in cART-treated SIV-infected macaques and compared these values to cART-untreated SIV-infected macaques. Results: Hepatic THPO transcription was downregulated during asymptomatic SIV infection concurrent with platelet decline. Hepatic THPO mRNA levels correlated with bone marrow megakaryocyte density. In contrast, plasma TGFβ levels were inversely correlated with hepatic THPO transcription and bone marrow megakaryocyte density. With cART treatment, plasma TGFβ levels and platelet count returned to values similar to those in uninfected macaques. Conclusions: TGFβ-mediated downregulation of hepatic THPO may lead to decline in platelet number during asymptomatic SIV infection, and cART may prevent platelet decline by normalizing plasma TGFβ levels.

Original languageEnglish (US)
Pages (from-to)510-516
Number of pages7
JournalJournal of acquired immune deficiency syndromes
Volume65
Issue number5
DOIs
StatePublished - Apr 15 2014

Keywords

  • HIV
  • Platelet
  • SIV
  • TGFβ
  • Thrombocytopenia
  • Thrombopoietin

ASJC Scopus subject areas

  • Infectious Diseases
  • Pharmacology (medical)

Fingerprint Dive into the research topics of 'TGFβ-mediated downregulation of thrombopoietin is associated with platelet decline in asymptomatic SIV infection'. Together they form a unique fingerprint.

  • Cite this